Lumira-sponsored SPAC seeks $100m from Nasdaq IPO

LAVA Medtech Acquisition Corp, a special purpose acquisition corporation, has priced its initial public offering on the Nasdaq Global Market to raise $100 million.

CanadaNorth AmericaUSIPOBriefs